Literature DB >> 2256716

Response of human endometrium and ovarian carcinoma cell-lines to photodynamic therapy.

G H Raab1, A F Schneider, W Eiermann, H Gottschalk-Deponte, R Baumgartner, W Beyer.   

Abstract

The response of the human gynecological carcinoma cell-lines HEC-1-A (endometrial carcinoma) and OvCar-3 (ovarian carcinoma) to photodynamic therapy in vitro was examined. The porphyrin compound Photosan III (Ph III) was used for photosensitization of the cells after incubation times of 24 h (HEC-1-A) and 48 h (HEC-1-A and OvCar-3). The Ph III doses varied from 0-10 micrograms/ml medium. Irradiation was performed with laser light at 630 nm. Irradiation doses up to 20 J/cm2 were applied at an irradiance of 40-100 mW/cm2. Cell vitality of the untreated control groups and of the therapy group was determined 48 h after irradiation, using the trypan blue exclusion test. The experimental results show that treatment of OvCar-3 cells with 10 J/cm2 resulted in a decrease in vitality dependent on photosensitizer dose (0-5 micrograms/ml, 48 h incubation time) but independent of the irradiance (40-100 mW/cm2). Complete cell death was observed after application of irradiation doses in the range of 5-20 J/cm2 combined with drug concentrations of 10-2.5 micrograms/ml, at a fixed incubation time of 48 h. HEC-1-A cells did not survive photodynamic therapy with 10 J/cm2 after incubation with 5 micrograms/ml for 48 h. After a shorter incubation time of 24 h, 10 micrograms/ml Ph III was necessary for the same effect. There was a maximum decrease in cell vitality when measured 48 h after irradiation. This was not improved at 72 h.

Entities:  

Mesh:

Year:  1990        PMID: 2256716     DOI: 10.1007/bf02389584

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  29 in total

1.  Identification of neoplastic versus normal cells in human cervical cell culture.

Authors:  B T Mossman; M J Gray; L Silberman; R L Lipson
Journal:  Obstet Gynecol       Date:  1974-05       Impact factor: 7.661

2.  Exposure (dose) tables for hematoporphyrin derivative photoradiation therapy.

Authors:  M W Berns; G S Berns; J Coffey; A G Wile
Journal:  Lasers Surg Med       Date:  1984       Impact factor: 4.025

3.  The treatment of vaginal recurrences of gynecologic malignancy with phototherapy following hematoporphyrin derivative pretreatment.

Authors:  B G Ward; I J Forbes; P A Cowled; M M McEvoy; L W Cox
Journal:  Am J Obstet Gynecol       Date:  1982-02-01       Impact factor: 8.661

4.  Photodynamic therapy of gynecologic neoplasms after presensitization with hematoporphyrin derivative.

Authors:  J S McCaughan; H F Schellhas; J Lomano; B H Bethel
Journal:  Lasers Surg Med       Date:  1985       Impact factor: 4.025

5.  Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R3230AC mammary adenocarcinomas of rats.

Authors:  R Hilf; D B Smail; R S Murant; P B Leakey; S L Gibson
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

6.  Photoradiation therapy for the treatment of malignant tumors.

Authors:  T J Dougherty; J E Kaufman; A Goldfarb; K R Weishaupt; D Boyle; A Mittleman
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

7.  Laser photoradiation therapy of cancer.

Authors:  A Dahlman; A G Wile; R G Burns; G R Mason; F M Johnson; M W Berns
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

8.  Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy.

Authors:  R C Benson; J H Kinsey; D A Cortese; G M Farrow; D C Utz
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

9.  Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models.

Authors:  S M Waldow; B W Henderson; T J Dougherty
Journal:  Lasers Surg Med       Date:  1987       Impact factor: 4.025

10.  [Photodynamic destruction of in vitro cultivated squamous cell carcinoma cells of the head and neck area].

Authors:  T P Wustrow; D Jocham; A Schramm; E Unsöld
Journal:  Laryngol Rhinol Otol (Stuttg)       Date:  1988-10
View more
  4 in total

Review 1.  Applications of Photodynamic Therapy in Endometrial Diseases.

Authors:  Gabriela Correia-Barros; Beatriz Serambeque; Maria João Carvalho; Carlos Miguel Marto; Marta Pineiro; Teresa M V D Pinho E Melo; Maria Filomena Botelho; Mafalda Laranjo
Journal:  Bioengineering (Basel)       Date:  2022-05-23

Review 2.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

3.  Enhancing endosomal escape of transduced proteins by photochemical internalisation.

Authors:  Kevin Mellert; Markus Lamla; Klaus Scheffzek; Rainer Wittig; Dieter Kaufmann
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

Review 4.  Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer.

Authors:  Scott C Hester; Maju Kuriakose; Christopher D Nguyen; Srivalleesha Mallidi
Journal:  Photochem Photobiol       Date:  2020-03-05       Impact factor: 3.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.